<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03941990</url>
  </required_header>
  <id_info>
    <org_study_id>RBHP 2018 MOISSET</org_study_id>
    <secondary_id>2018-001296-20</secondary_id>
    <nct_id>NCT03941990</nct_id>
  </id_info>
  <brief_title>Lumbar Puncture in Emergency Under Nitrous OXide</brief_title>
  <acronym>LENOX</acronym>
  <official_title>Impact of 50% Nitrous Oxide Inhalation on Pain Induced by Lumbar Puncture in Emergency: a Double-blind Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Inserm U1107, NeuroDol</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université Clermont-Auvergne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lumbar puncture (LP) is a frequent exam that can cause pain and anxiety. In a scheduled
      setting, it has been shown that nitrous oxide use during the procedure was able to reduce
      both pain and anxiety. The goal of this trial is to confirm these results in a more
      heterogeneous group of patients having a LP, in an emergency setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nitrous oxide (N2O) has analgesic and anxiolytic properties that are known for more than a
      century. Nonetheless, it's use during lumbar puncture in adults has only been investigated in
      a scheduled setting.Thus, this study is designed to evaluate the analgesic effect of N2O on
      the pain induced during lumbar puncture.

      Patients with urgent lumbar puncture realized for diagnosis purposes will be randomized in 2
      groups. One group will inhale N2O for the 5 minutes before the puncture and during the rest
      of the procedure. The second group will inhale compressed air during the same period. Neither
      the investigator realizing the lumbar puncture, nor the patient will know which type of gaz
      they are inhaling (double-blinding).

      The maximal pain level that occurred during the procedure will be evaluated on a Numerical
      Rating Scale (NRS). NRS will also be used to evaluate the maximal anxiety induced by the
      procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 27, 2019</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>1:1 randomization to receive experimental treatment (50% N2O - 50% O2) or placebo (Medical Air: 22% O2 - 78% N2).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>double blinding, gas bottles are in undistinguishable boxes, and each gas mask will be filled with odorous ink masking the sweet flavour of N2O. Neither the patient nor the person doing the LP and/or the evaluation of pain and anxiety will know the treatment used</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal pain perceived during the lumbar puncture evaluated using a simple numeric 0-10 pain scale</measure>
    <time_frame>2-3 minutes after the end of gas inhalation</time_frame>
    <description>Maximal level of pain during lumbar puncture. The patient will be asked to circle the digit that best describes the maximal level of pain felt during the procedure. If the patient is too painful and/or is incapacitated, the collection notebook will be fulfilled by the care provider after asking the following question: &quot;On a scale of 0 to 10, 0 being the absence of pain and 10 the maximal pain you can imagine, what is the digit best describing the maximal pain you felt during the procedure?&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximal anxiety perceived during lumbar puncture evaluated using a simple numeric 0-10 scale</measure>
    <time_frame>2-3 minutes after the end of gas inhalation</time_frame>
    <description>Proportion of patients with significant anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>From the beginning of gas inhalation to a minimum of 2 hours later</time_frame>
    <description>Every side effect reported by the patients attributable to gas inhalation during the procedure up to emergency service discharge. Presence, intensity and reversibility will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spinal puncture duration</measure>
    <time_frame>2-3 minutes after the end of lumbar puncture</time_frame>
    <description>Comparison of LP duration between both groups measured in minutes (from the beginning of gas inhalation to needle removal).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of attempts before successful LP</measure>
    <time_frame>2-3 minutes after the end of lumbar puncture</time_frame>
    <description>Comparison of number of attempts needed to get spinal fluid, defined as number of needle removals for a single exam.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>2-3 minutes after the end of gas inhalation</time_frame>
    <description>overall satisfaction based on a 0-10 score and proportion of patients that would accept another lumbar puncture in the same conditions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blinding quality</measure>
    <time_frame>2-3 minutes after the end of gas inhalation</time_frame>
    <description>Assessment of blinding in clinical trials (according to Bang et al. 2004)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Induced cost</measure>
    <time_frame>through study completion, an average 4 months</time_frame>
    <description>supplementary cost induced by the use of nitrous oxide inhalation for a total of 88 patients throughout the study (gas and consumables such as masks and pipes)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Pain</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Nitrous oxyde</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>will inhale experimental treatment throughout the entire procedure (50% N2O - 50% 02)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>will inhale medical air throughout the entire procedure (22% O2 + N2 Q.S.)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fixed 50:50 mixture of nitrous oxide and oxygen</intervention_name>
    <description>Gaz inhalation will start 5 minutes before the puncture and will be continued until the end of the procedure.</description>
    <arm_group_label>Nitrous oxyde</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>inhale medical air (22% O2 - 78% N2)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients coming in emergency service who need a lumbar puncture in emergency for
             a diagnostic purpose

          -  at least 18

          -  affiliated to the French state healthcare insurance system

          -  able to give consent to participation

        Exclusion Criteria:

          -  Previous use of nitrous oxide (medical or recreational)

          -  Contra-indication to nitrous oxide use

          -  Face mask phobia

          -  Stage II obesity (BMI &gt; 35)

          -  Hemodynamic instability and/or any case when coagulation results cannot be waited

          -  Cognitive condition defined by a previous Mini Mental State Examination &lt; 24/30

          -  Confusion or any consciousness disorder that might interfere with judgment or consent

          -  Patient unable to communicate verbally

          -  Patient placed under a legal protection measure (tutorship, curatorship or a mandate)

          -  Any medical condition that might contra-indicate medical research, in physician's
             opinion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lise LACLAUTRE, Dr</last_name>
    <phone>(0)473754963</phone>
    <email>promo_interne_drci@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <state>Auvergne Rhône-Alpes</state>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lise LACLAUTRE, MD-PhD</last_name>
      <email>promo_interne_drci@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Xavier MOISSET, MD-PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ludovic MIRAILLET, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeannot SCHMIDT, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julien RACONNAT, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Farés MOUSTAFA, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christine CARRIAS, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas DUBLANCHET, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra TAZE, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sonia AJIMI, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marjolaine BOREL, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marine MONDET, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mathilde QUINTY, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie VALETTE, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas FLEUCHOT, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mélissa FLEURY, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virginie GOULVIN, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bastien MALOSSANE, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent MARQUET, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rémi MARTEL, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marion PONCET, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie THOMAS, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Herres J, Chudnofsky CR, Manur R, Damiron K, Deitch K. The use of inhaled nitrous oxide for analgesia in adult ED patients: a pilot study. Am J Emerg Med. 2016 Feb;34(2):269-73. doi: 10.1016/j.ajem.2015.10.038. Epub 2015 Oct 24.</citation>
    <PMID>26585197</PMID>
  </reference>
  <reference>
    <citation>Bang H, Ni L, Davis CE. Assessment of blinding in clinical trials. Control Clin Trials. 2004 Apr;25(2):143-56.</citation>
    <PMID>15020033</PMID>
  </reference>
  <reference>
    <citation>Koscielniak-Nielsen Z, Hesselbjerg L, Brushøj J, Jensen MB, Pedersen HS. EMLA patch for spinal puncture. A comparison of EMLA patch with lignocaine infiltration and placebo patch. Anaesthesia. 1998 Dec;53(12):1218-22.</citation>
    <PMID>10193230</PMID>
  </reference>
  <reference>
    <citation>Lavi R, Yarnitsky D, Rowe JM, Weissman A, Segal D, Avivi I. Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial. Neurology. 2006 Oct 24;67(8):1492-4. Erratum in: Neurology. 2007 Feb 27;68(9):711. Yernitzky, D [corrected to Yarnitsky, D].</citation>
    <PMID>17060584</PMID>
  </reference>
  <reference>
    <citation>Lukas A, Niederecker T, Günther I, Mayer B, Nikolaus T. Self- and proxy report for the assessment of pain in patients with and without cognitive impairment: experiences gained in a geriatric hospital. Z Gerontol Geriatr. 2013 Apr;46(3):214-21. doi: 10.1007/s00391-013-0475-y.</citation>
    <PMID>23474866</PMID>
  </reference>
  <reference>
    <citation>Moisset X, Ruet A, Brochet B, Planche V, Jaffeux P, Gilleron V, Ong N, Clavelou P. Who Performs Lumbar Puncture, How Many Do They Perform, How and Why? A Retrospective Study of 6,594 Cases. Eur Neurol. 2016;76(1-2):8-11. doi: 10.1159/000447452. Epub 2016 Jun 24.</citation>
    <PMID>27336667</PMID>
  </reference>
  <reference>
    <citation>Moisset X, Sia MA, Pereira B, Taithe F, Dumont E, Bernard L, Clavelou P. Fixed 50:50 mixture of nitrous oxide and oxygen to reduce lumbar-puncture-induced pain: a randomized controlled trial. Eur J Neurol. 2017 Jan;24(1):46-52. doi: 10.1111/ene.13127. Epub 2016 Sep 25.</citation>
    <PMID>27666149</PMID>
  </reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 2, 2019</study_first_submitted>
  <study_first_submitted_qc>May 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2019</study_first_posted>
  <last_update_submitted>February 18, 2020</last_update_submitted>
  <last_update_submitted_qc>February 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spinal puncture</keyword>
  <keyword>Nitrous oxide</keyword>
  <keyword>Pain</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Emergency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

